Laura Hubbs
Pain Medicine · Norfolk, VANPI 1417428715
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 156 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 15 manufacturers, the largest accounting for just 23.3% — the pattern of someone who eats at a lot of different presentations.
Across 156 payments — averaging $19.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$708
- Lundbeck LLC$671
- Pfizer$525
- Collegium Pharmaceutical, Inc.$433
- Vertex$129
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$113
- plus $456 from 9 others
What the payments were for
- Food & beverage$3,035100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 39 | $708 |
| Lundbeck LLC | 28 | $671 |
| Pfizer | 35 | $525 |
| Collegium Pharmaceutical, Inc. | 22 | $433 |
| Vertex | 5 | $129 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $113 |
| Lilly USA, LLC | 5 | $102 |
| Axsome Therapeutics, Inc. | 3 | $77 |
| Averitas Pharma Inc. | 3 | $58 |
| Tersera Therapeutics LLC | 2 | $55 |
| Idorsia Pharmaceuticals US Inc | 3 | $52 |
| Merz Pharmaceuticals, LLC | 2 | $48 |
| Johnson & Johnson | 1 | $27 |
| Abbott | 1 | $22 |
| Scilex Pharmaceuticals Inc. | 1 | $15 |
How this compares
$3,035 in reported general payments places this provider in the 65th percentile of 150 pain medicine providers in Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OxycontinOxycodone Hcl | 33 | $56,158 |
| Nurtec OdtRimegepant Sulfate | 20 | $34,389 |
| Oxycodone Hcl | 376 | $16,064 |
| Fentanyl | 71 | $14,002 |
| Xtampza ErOxycodone Myristate | 11 | $10,475 |
| Morphine Sulfate ErMorphine Sulfate | 128 | $5,728 |
| Hydromorphone Hcl | 87 | $3,057 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 72 | $2,477 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 73 | $2,391 |
| Morphine Sulfate | 35 | $2,077 |
| Naloxone Hcl | 33 | $2,010 |
| Lidocaine | 11 | $1,982 |
| Methadone Hcl | 52 | $1,741 |
| Gabapentin | 98 | $1,337 |
| Tizanidine Hcl | 54 | $1,306 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerNurtec Odt | $525 | $34,38920 claims |
| Collegium Pharmaceutical, Inc.Xtampza Er | $433 | $10,47511 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 150 pain medicine providers in Virginia.
Other pain medicine in Norfolk
- Antonio Quidgley-NevaresNorfolk$14K
- Robert HansenNorfolk$9K
- Melissa LewinNorfolk$5K
- Chheany UngRoanoke$198K
- Daniel KendallMc Lean$100K
- Steven GershonVirginia Beach$78K
- Jared DavisFishersville$45K
- Nameer HaiderWoodbridge$36K
- Lynn KohanCharlottesville$30K
- George BaylorSalem$24K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.